Kliniczny Szpital Wojewodzki nr. 1 Klinika Dermatologii

Rzeszów 35-055

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed